Search clinical trials for: 18F-FDG PET combined with CT without injection

Total 266 results

University Hospital, Caen

Completed

Performance of PET 18 F-FDG Coupled to CT With Contrast Injection Iodized in the Diagnosis of Early Recurrences of Head and Neck Carcinoma Treated With Concurrent Chemoradiation. Comparison With 18F-FDG PET Coupled With CT Not Injected With Filling CT Standard Injection (TEPVAD)

Squamous Cell Carcinoma of the Head and Neck

France
Ohio State University Comprehensive Cancer Center

Completed

Fludeoxyglucose F 18 PET/CT Imaging in Finding Cancer in Patients Undergoing Surgery for Solid Tumors

Unspecified Adult Solid Tumor, Protocol Specific

United States
Peking University

Unknown

Explore the Clinical Value of 68Ga-DOTANOC PET/CT and 18F-FDG PET/CT in Neuroendocrine Neoplasms

Neuroendocrine Tumors

China
University of Lausanne Hospitals
George Coukos, MD PhD, Head of oncology

Recruiting

68Ga-NODAGA-RGD PET/ CT for Tumoral Neoangiogenesis

Pathological Angiogenesis

Switzerland
National Cancer Institute (NCI)

Completed

Transformation of Plexiform Neurofibromas to Malignant Peripheral Nerve Sheath Tumors in Neurofibromatosis Type 1

Neurofibromatosis | MPNST

United States
Johns Hopkins University
National Institutes of Health (NIH)

Recruiting

Biodistribution and Pathophysiology Study of 18F-Fluorodeoxysorbitol (18F-FDS) in Diseased Patients

Invasive Fungal Infections | Inflammatory Disease | Oncologic Disease | Enterobacterial Infections

United States
Peking Union Medical College Hospital

Active, not recruiting

FAPI PET for Response Evaluation and Prognosis Prediction in Liver and Biliary Cancer Patients Treated With PD-1 Combination Therapy

Hepatocellular Carcinoma | Bile Duct Cancer

China
National Cancer Institute (NCI)

Recruiting

18F-Fluciclovine PET/CT in Multiple Myeloma

Multiple Myeloma | Relapsed and/or Refractory Multiple Myeloma (RRMM) | Newly Diagnosed Multiple Myeloma (NDMM)

United States
Central Hospital, Nancy, France

Not yet recruiting

Development of Inflammation and Fibrosis Index, Combining MRI and PET 18F-FDG, in Patient's With Crohn's Disease (FILM)

Crohn Disease
Peking University Cancer Hospital & Institute

Unknown

Positron Nuclide Labeled NOTA-FAPI PET Study in Lymphoma

Lymphoma | Positron-Emission Tomography | Tumor, Solid

China
University of Sao Paulo

Unknown

Use of Positron Emission Tomography/Computed Tomography (PET/CT) to Assess Tumor Response to Neoadjuvant Treatment for Distal Rectal Cancer

Rectal Cancer

Brazil
British Columbia Cancer Agency

Recruiting

Dynamic Whole Body Positron Emission Tomography/Computed Tomography Imaging

Prostatic Neoplasms | Prostate Cancer | Neuroendocrine Tumors | Neuroblastoma | Carcinoid Tumor | Paraganglioma

Canada
Harbin Medical University

Unknown

Perfusion and Hypoxia Evaluation in Tumors Using 18F-FDG PET/CT

Perfusion and Hypoxia

China
Valentina Garibotto

Recruiting

Dynamic Whole-body PET/CT Imaging in Clinical Oncology (Dynamic PET/CT)

Cancer

Switzerland
Progenics Pharmaceuticals, Inc.

Completed

Study of 18F-DCFPyL PET/CT Imaging in Patients With Prostate Cancer (OSPREY)

Prostate Cancer

United States, Canada
GE Healthcare

Recruiting

A Study to Evaluate GEH200520/GEH200521 (18F) Safety and Tolerability When Used for PET Scans in Patients With Solid Tumour Malignancies

Oncology | Malignant Solid Tumor

Netherlands
University of Wisconsin, Madison
National Cancer Institute (NCI)

Completed

Pilot Study of Biomarkers of Response to Immune Checkpoint Blockade in Metastatic Melanoma

Melanoma

United States
GE Healthcare
Laboratory Corporation of America

Not yet recruiting

Study to Evaluate Safety and Dosimetry of [18F]GEH121224 in Patients With Locally Advanced or Metastatic Breast Cancer

Breast Cancer

United States
University of Utah

Active, not recruiting

Amyloid Plaque Deposition in Chemotherapy-Induced Cognitive Impairment

Breast Cancer

United States
Odense University Hospital

Unknown

Dual PETOvac - Dual Time PET/CT in the Preoperative Assessment of Ovarian Cancer (Dual PETOvac)

Ovarian Cancer

Denmark
GE Healthcare
PPD; Fortrea

Not yet recruiting

A Phase 1, Dose-Escalation, Positron Emission Tomography Study to Assess the Safety, Pharmacokinetics, Dosimetry and Biodistribution of GEH200521 (18F) Injection Co-Administered With GEH200520 Injection in Healthy Volunteers

Healthy Volunteers

United States
Jinling Hospital, China

Not yet recruiting

To Compare the Clinical Application of 18F-LNC1007 Injection PET/CT and 18F-FDG PET/CT (18F-LNC1007)

Tumour
University of Utah

Terminated

Assessment of Primary and Metastatic Brain Tumor Hypoxia With Fluoromisonidazole, FDG and Water

Brain Cancer

United States
University of Utah

Completed

A Multi-modality Imaging Assessment of Chemobrain (Chemobrain)

Cancer

United States
Columbia University
National Center for Research Resources (NCRR)

Terminated

Use of PET Imaging to Distinguish Malignant From Benign IPMN

Pancreatic Cancer | Neoplasm

United States
Washington University School of Medicine

Recruiting

Immune Checkpoint Blockade Therapy Using 18F-FLT PET/CT

Cancer

United States
Central Hospital, Nancy, France

Completed

Evaluation of a Metabolic Preparation by a Low-carbohydrate Diet as Atkins-diet to Help in Detecting Infective Endocarditis by 18F-FDG PET (TEPEIR)

Infective Endocarditis

France
British Columbia Cancer Agency

Withdrawn

FDGal PET/CT to Detect Hepatocellular Carcinoma

Liver Cirrhosis | Hepatocellular Carcinoma | Chronic Liver Disease

Canada
Amsterdam UMC, location VUmc
Radboud University Medical Center; Leiden University Medical Center; Academisch... and other collaborators

Completed

Early Biomarker With 18F-FDG PET for Treatment Optimization of Anti-EGFR Therapy in Patients With Metastatic Colorectal Cancer.

Colorectal Cancer

Netherlands
Affiliated Cancer Hospital & Institute of Guangzhou...

Not yet recruiting

18F-FAPI and 18F-FDG PET/CT in Patients With Various Types of Cancer (FAPI-VTC)

Cancer
Nanjing Medical University

Unknown

Individualized Precise Radiotherapy With the Guidance of Radiosensitivity of Locally Advanced Cervical Cancer (PROGRAMMA)

Cervical Cancer

China
VA Greater Los Angeles Healthcare System
Lantheus Medical Imaging

Not yet recruiting

PSMA PET Scan and mpMRI for Prostate Cancer Detection

Prostate Cancer Diagnosis

United States
British Columbia Cancer Agency

Not yet recruiting

Preliminary Assessment of [18F]BL40 in PET/CT Scans

Multiple Myeloma | Waldenström Macroglobulinemia | Mantle Cell Lymphoma | Marginal Zone Lymphoma | Chronic Lymphocytic Leukemia | Diffuse Large B-cell Lymphoma

Canada
Boston Children's Hospital
National Institutes of Health (NIH)

Enrolling by invitation

Pain in Fibrous Dysplasia

Fibrous Dysplasia/McCune-Albright Syndrome

United States
University of Alabama at Birmingham

Recruiting

Molecular Imaging Probes to Inform Heterogeneity in Idiopathic Pulmonary Fibrosis

Idiopathic Pulmonary Fibrosis

United States
Medical University of Vienna

Not yet recruiting

Organ Interaction Patterns in Healthy Individuals for Improved PET/CT Diagnostics (Healthy-PET)

Healthy
Peking University Cancer Hospital & Institute

Recruiting

Positron Nuclide Labeled DOTA-FAPI PET Study in Colocrectal Cancer

Colorectal Cancer | Positron-Emission Tomography | Tumor, Solid

China
The First Affiliated Hospital of Xiamen University

Completed

68Ga-FAPI-RGD PET/CT for Dual Integrin αvβ3 and FAP-targeted Imaging in Patients With Various Types of Cancer and Compared With 18F-FDG

Positron-Emission Tomography | Tumor, Solid

China
British Columbia Cancer Agency

Terminated

PET/CT Guided Fulvestrant Therapy for Patients With Recurrent or Metastatic Breast Cancer

Breast Cancer

Canada
Merck Sharp & Dohme LLC

Terminated

A Study to Evaluate [18F]-FDG PET (Fluorodeoxyglucose-positron) in Patients With Pancreatic Cancer (MK-0000-144)

Advanced Pancreatic Adenocarcinoma
Radboud University Medical Center
UMC Utrecht; Amsterdam UMC, location VUmc; St. Antonius Hospital; Dijklander Ziekenhuis and other collaborators

Recruiting

The Beneficial Value of PET/CT in the Follow-up of Stage III Non-small Cell Lung Cancer Patients (NVALT31-PET)

Stage III Non-small Cell Lung Cancer

Netherlands
Ruijin Hospital

Recruiting

Prediction of Neoadjuvant Chemotherapy Efficacy in Locally Advanced Gastric Cancer

Gastric Cancer

China
Peking Union Medical College Hospital

Unknown

68Ga-FAPI-04 and 18F-FDG PET/CT in Patients With Epithelial Ovarian Cancer: Compared With Histological Findings

Epithelial Ovarian Cancer

China
The First Affiliated Hospital of Xiamen University

Recruiting

68Ga-FAPI-LM3 PET/CT Imaging in Patients With FAP/SSTR2 Positive Disease and Compared With 18F-FDG

Positron-Emission Tomography | FAP | SSTR2

China
Kantonsspital Baden

Completed

Cold Induced Futile Cycles In White Adipose Tissue (Metabol)

Metabolism Disorder

Switzerland
Memorial Sloan Kettering Cancer Center

Completed

Using Fluorine-18-Labeled Fluoro-Misonidazole Positron Emission Tomography To Detect Hypoxia in Head and Neck Cancer Patients

Head and Neck Cancer

United States
University of Utah
National Cancer Institute (NCI); National Institutes of Health (NIH)

Terminated

FDG-Positron Emission Tomography (PET)/CT In the Evaluation of Persistent Febrile Neutropenia in Cancer Patients

Cancer

United States
British Columbia Cancer Agency

Approved for marketing

18F-FDG PET Imaging in Cardiac Sarcoidosis

Cardiac Sarcoidosis

Canada
First Affiliated Hospital Xi'an Jiaotong University

Not yet recruiting

Study of 18F-FAPI Applied to Gastrointestinal Cancer

Gastrointestinal Cancer
British Columbia Cancer Agency

Recruiting

DOTATOC PET/CT for Imaging NET Patients

Pituitary Adenoma | Neuroendocrine Tumors | Medulloblastoma | Small-cell Lung Cancer | Neuroblastoma | Meningioma | Merkel Cell Carcinoma | Pheochromocytoma | Paraganglioma | Gastrinoma | Glucagonoma | Insulinoma | Vipoma | Carcinoid | Ganglioneuroma | Medullary Carcinoma

Canada

Search clinical trials for: 18F-FDG PET combined with CT without injection

Sponsors and Collaborators

Medical Conditions

Drug Interventions

CROs by country

CROs in Rwanda

Conditions

Rare Diseases

Drug Interventions

Dietary Supplements

Sponsor/Collaborators

Locations